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CORRECTION Open Access
Correction to: Azithromycin has enhanced
effects on lung fibroblasts from idiopathic
pulmonary fibrosis (IPF) patients compared
to controls
Kristina Krempaska1,2,3, Sandra Barnowski1,2, Jacopo Gavini4, Nina Hobi5,6, Simone Ebener1,2, Cedric Simillion2,7,
Andrea Stokes1,2, Ronja Schliep8, Lars Knudsen8,9, Thomas K. Geiser1,2 and Manuela Funke-Chambour1,2*
Correction to: Respir Res
https://doi.org/10.1186/s12931-020-1275-8
After publication of our article [1], we have been noti-
fied that an extra alpha symbol (α) was mistakenly added
at the beginning of the title.
The original article has been corrected.
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